Brind.
Part of Donald Trump instructed the FDA to accelerate the drug review process.

How could the FDA's nutrition update review affect General Mills' operations?

Possible What happens if… A possibility worth considering, not a forecast.

General Mills may face compliance costs from new infant formula nutrient standards. The FDA's ongoing nutrition review, part of the Trump administration's Operation Stork Speed initiative, proposes significant changes to nutrient requirements for infant formula. For manufacturers like General Mills, these changes mandate product reformulation and adherence to new standards, which could increase operational costs. The initial phase of the review proposes tripling the required amount of iodine from 5 micrograms to 15 micrograms and doubling the minimum required amount of vitamin D from 1 to 2 micrograms. However, the review is phased, meaning these changes may not appear on formula cans for several years.

Reported by 1 independent outlet Written Oct 30
Effect
Mild negative
How direct
Brind's reasoning
When
Over the long term
The story
Gone quiet

How it reaches General Mills

Reported by news outletsBrind's reasoning

Tap any step to see the evidence behind it.

The facts so far

As reported. Each one links to where it comes from.

  • The review is part of the Trump administration’s Operation Stork Speed initiative, announced in March 2025.wtxl.com
  • The proposed rule triples the amount of iodine required in infant formula, from 5 micrograms to 15.wtxl.com
  • The proposed rule doubles the minimum required amount of vitamin D from 1 to 2 micrograms.wtxl.com
  • Abrams noted that changes recommended today are not likely to show up on the can of formula for several years.wtxl.com

Why it matters

For General Mills, compliance with new federal nutrient standards represents a significant operational risk and potential cost increase. As a major producer of infant formula, the company must manage the complex logistics of product reformulation, which involves sourcing new ingredients and re-validating production processes to meet the FDA's rigorous scientific standards.

The FDA holds broad regulatory power over the infant formula industry, and this review is part of a larger, phased effort to update requirements for all 30 nutrients. The agency is also seeking public input from industry regarding potential new mandatory nutrients, such as long-chain fatty acids like ARA and DHA, which could further expand the scope of required changes.

What we don't know yet

  • When will the subsequent phases of the nutrient review be completed?
  • Will the FDA mandate the inclusion of nutrients like ARA and DHA in infant formula?

What would change this answer

The FDA accelerates the timeline for the review phasesThe pressure on General Mills to reformulate and implement changes will become immediate, increasing the likelihood and speed of cost increases.
The FDA decides to delay or scale back the proposed nutrient changesThe operational changes and associated costs for General Mills would be reduced or postponed indefinitely.

Who else could feel it

Other possible ripples from the same event.

Reporting

Keep going

Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.